Drug Discovery Services Market research report Forecast to 2030

Category : Pharmaceuticals and Healthcare

Publisher : MRFR

Published Date : Apr 2023

Pages : 110

Request Sample

Check Discount

Request Enquiry

Buy Report

Licence Type:

Single User - $4950

Multi User - $7250

Enterprise User - $7250

Drug Discovery Services Market Research Report Information By Drug Type (Small Molecule Drug, Biologics), By Type (DMPK, Pharmaceutical Services, Others), By Therapeutic Area (Oncology, Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) - Market Forecast Till 2030

Drug Discovery Services Market Overview:

The Drug Discovery Services market industry is projected to exhibit a significant CAGR of 13.92% during the forecast period. Developing Re-appropriating of Drug Advancement and Expanding Exploration and Improvement Expenses are the key market drivers upgrading the Drug Discovery Services market development.

Drug and biopharmaceutical organizations are picking completely coordinated or practical rethinking services for drug innovative work from the early improvement stage to the late-stage advancement stage due to expanded Research and development consumptions. While drug organizations are under extraordinary strain to monitor fixed costs, re-appropriating has arisen as a strategic answer for the absence of inside assets required for new item improvement. Enormous pharma firms are changing to a more streamlined corporate methodology that unequivocally stresses rethinking.

Expanding need for imaginative therapeutics across a scope of restorative objectives. Drug-finding services Rising requirement for imaginative therapies for constant sicknesses and headways in the medical care industry are anticipated to be the primary drivers of market development. Drug and biopharmaceutical organizations actually contract their innovative work (Research and Development) activities to CROs, who offer Research and development services and make commitment models to boost Research and development productivity. Legislatures and drug enterprises are compelled to search for answers and lift their interest in clinical preliminaries because of the expanded weight of persistent sicknesses. Subsequently, there will be a more prominent requirement for drug discovery services.

Drug Discovery Services Market Segmentation:

Based on Drug Type, the Drug Discovery Services market has been classified into Small Molecule Drugs, Biologics’ Based on type, the market is divided into Drug metabolism and pharmacokinetics (DMPK) Services, Pharmaceutical Services, and Others. Therapeutic Areas of the Drug Discovery Services market are bifurcated into data into Oncology, Others.

Drug Discovery Services Regional Analysis:

North America is likely to drive the global Drug Discovery Services market due to the higher interest in drug discovery Research and development, critical firms with laid-out research foundations, and specialized upgrades. As rethinking is at this point not just about reducing expenses, a developing requirement for viability, quality, and development is expected to help industry extension.

The Asia Pacific drug discovery services market is anticipated to develop the highest growth owing to the accessibility of qualified individuals, less expensive costs, a successful administrative climate, and great information, the Region is rapidly turning into a center for re-appropriating drug improvement exercises. The second-biggest drug market on the planet, Japan, is expected to furnish CROs with a sizable potential, driving the business.

The fast improvement of innovation and the development of metropolitan regions impel the European drug discovery services market. The improvement of biologics and biosimilars has seen an expansion in speculation from biopharmaceutical firms, which is liable for the ascent in the number of approved drugs in Europe. The European drug discovery services market is expected to be driven by expanding consumptions made by many significant organizations in different clinical and non-clinical examination exercises that are moved to a few CRO specialist co-ops and help with proficient item improvement.

Drug Discovery Services Industry Major Players:

Abbott Laboratories Inc., Advinus Therapeutics, Albany Molecular Research Inc. (AMRI), Aurigene, Agilent Technologies Ubiquigent, AstraZeneca PLC, Retrogenix (U.K.), Charles River Laboratories International, Eurofins, and Liverpool ChiroChem Ltd. and Among Others

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

1.1 OVERVIEW

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 RESEARCH OBJECTIVE

2.4 MARKET STRUCTURE

2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.4 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 INCREASING RESEARCH & DEVELOPMENT EXPENDITURE

4.2.2 RISING DRUG DEVELOPMENT OUTSOURCING

4.3 RESTRAINTS

4.3.1 STRINGENT REGULATORY POLICIES AND COSTS ASSOCIATED TO DRUG DISCOVERY

4.4 OPPORTUNITY

4.4.1 TECHNOLOGICAL ADVANCEMENTS IN DRUG DISCOVERY

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 CUSTOMER ACQUISITION (PREPURCHASE QUERY)

5.1.2 SERVICE CUSTOMIZATION

5.1.2.1 R&D

5.1.2.2 GOOD LABORATORY PRACTICES (GLP)

5.1.3 CUSTOMER PURCHASE SUPPORT

5.1.4 CUSTOMER FULFILMENT & POST-PURCHASE SUPPORT

5.2 PORTER'S FIVE FORCES MODEL

5.2.1 THREAT OF NEW ENTRANTS

5.2.2 BARGAINING POWER OF SUPPLIERS

5.2.3 THREAT OF SUBSTITUTES

5.2.4 BARGAINING POWER OF BUYERS

5.2.5 INTENSITY OF RIVALRY

5.3 COVID-19 IMPACT ON THE DRUG DISCOVERY SERVICES MARKET

5.3.1 IMPACT ON R&D

5.3.2 IMPACT ON PRICING

5.3.3 IMPACT ON MARKET GROWTH

6 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE

6.1 OVERVIEW

6.2 SMALL MOLECULE DRUG

6.3 BIOLOGICS DRUG

7 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES

7.1 OVERVIEW

7.2 DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES

7.3 PHARMACEUTICAL SERVICES

7.4 MEDICINAL CHEMISTRY

7.5 BIOLOGICAL SERVICES

7.6 MEDICATION

8 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA

8.1 OVERVIEW

8.2 ONCOLOGY

8.3 CARDIOVASCULAR DISEASES

8.4 RESPIRATORY DISEASES

8.5 DIABETES

8.6 OTHERS

9 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY

9.1 OVERVIEW

9.2 HIGH THROUGHPUT SCREENING

9.3 BIOCHIPS

9.4 PHARMACOGENOMICS AND PHARMACOGENETICS

9.5 METABOLOMICS

9.6 OTHERS

10 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY END USER

10.1 OVERVIEW

10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

10.3 RESEARCH & ACADEMIC INSTITUTES

10.4 OTHERS

11 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY REGION

11.1 OVERVIEW

11.2 NORTH AMERICA

11.2.1 US

11.2.2 CANADA

11.3 EUROPE

11.3.1 GERMANY

11.3.2 FRANCE

11.3.3 UK

11.3.4 ITALY

11.3.5 SPAIN

11.3.6 REST OF EUROPE

11.4 ASIA-PACIFIC

11.4.1 CHINA

11.4.2 JAPAN

11.4.3 INDIA

11.4.4 AUSTRALIA

11.4.5 SOUTH KOREA

11.4.6 REST OF ASIA-PACIFIC

11.5 REST OF THE WORLD

11.5.1 MIDDLE EAST

11.5.2 AFRICA

11.5.3 LATIN AMERICA

12 COMPETITIVE LANDSCAPE

12.1 OVERVIEW

12.2 COMPETITIVE BENCHMARKING

12.3 MAJOR GROWTH STRATEGY IN DRUG DISCOVERY SERVICES MARKET

12.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN DRUG DISCOVERY SERVICES MARKET

12.5 KEY DEVELOPMENTS & GROWTH STRATEGIES

12.5.1 SERVICE LAUNCH

12.5.2 MERGERS & ACQUISITIONS

12.5.3 PARTNERSHIP/COLLABORATION

12.6 MAJOR PLAYERS SALES ANALYSIS

12.6.1 SALES & OPERATING INCOME, 2021 (USD MILLION)

12.6.2 MAJOR PLAYERS R&D ANALYSIS, 2021 (USD MILLION)

13 COMPANY PROFILE

13.1 THERMO FISHER SCIENTIFIC INC.

13.1.1 COMPANY OVERVIEW

13.1.2 FINANCIAL OVERVIEW

13.1.3 SERVICES OFFERED

13.1.4 KEY DEVELOPMENTS

13.1.5 SWOT ANALYSIS

13.1.6 KEY STRATEGIES

13.2 ARAGEN LIFE SCIENCES PVT. LTD.

13.2.1 COMPANY OVERVIEW

13.2.2 FINANCIAL OVERVIEW

13.2.3 SERVICES OFFERED

13.2.4 KEY DEVELOPMENTS

13.2.5 KEY STRATEGIES

13.3 PIRAMAL PHARMA SOLUTIONS

13.3.1 COMPANY OVERVIEW

13.3.2 FINANCIAL OVERVIEW

13.3.3 SERVICES OFFERED

13.3.4 KEY DEVELOPMENTS

13.3.5 KEY STRATEGIES

13.4 CURIA GLOBAL, INC.

13.4.1 COMPANY OVERVIEW

13.4.2 FINANCIAL OVERVIEW

13.4.3 SERVICES OFFERED

13.4.4 KEY STRATEGIES

13.5 CHARLES RIVER LABORATORIES

13.5.1 COMPANY OVERVIEW

13.5.2 FINANCIAL OVERVIEW

13.5.3 SERVICES OFFERED

13.5.4 KEY DEVELOPMENTS

13.5.5 SWOT ANALYSIS

13.5.6 KEY STRATEGIES

13.6 EUROFINS SCIENTIFIC

13.6.1 COMPANY OVERVIEW

13.6.2 FINANCIAL OVERVIEW

13.6.3 SERVICES OFFERED

13.6.4 KEY DEVELOPMENTS

13.6.5 SWOT ANALYSIS

13.6.6 KEY STRATEGIES

13.7 IQVIA

13.7.1 COMPANY OVERVIEW

13.7.2 FINANCIAL OVERVIEW

13.7.3 SERVICES OFFERED

13.7.4 KEY DEVELOPMENTS

13.7.5 SWOT ANALYSIS

13.7.6 KEY STRATEGIES

13.8 EVOTEC

13.8.1 COMPANY OVERVIEWS

13.8.2 FINANCIAL OVERVIEW

13.8.3 SERVICES OFFERED

13.8.4 KEY DEVELOPMENTS

13.8.5 KEY STRATEGIES

13.9 WUXI APPTEC CO., LTD.

13.9.1 COMPANY OVERVIEW

13.9.2 FINANCIAL OVERVIEW

13.9.3 SERVICES OFFERED

13.9.4 KEY DEVELOPMENTS

13.9.5 SWOT ANALYSIS

13.9.6 KEY STRATEGIES

13.10 LABORATORY CORPORATION OF AMERICA HOLDINGS

13.10.1 COMPANY OVERVIEW

13.10.1 FINANCIAL OVERVIEW

13.10.2 SERVICES OFFERED

13.10.3 KEY DEVELOPMENTS

13.10.4 KEY STRATEGIES

13.11 SELVITA

13.11.1 COMPANY OVERVIEW

13.11.2 FINANCIAL OVERVIEW

13.11.3 SERVICES OFFERED

13.11.4 KEY DEVELOPMENTS

13.11.5 SWOT ANALYSIS

13.11.6 KEY STRATEGIES

13.12 SYGNATURE DISCOVERY

13.12.1 COMPANY OVERVIEW

13.12.2 FINANCIAL OVERVIEW

13.12.3 SERVICES OFFERED

13.12.4 KEY DEVELOPMENTS

13.12.5 SWOT ANALYSIS

13.12.6 KEY STRATEGIES

13.13 SYMERES

13.13.1 COMPANY OVERVIEW

13.13.2 FINANCIAL OVERVIEW

13.13.3 SERVICES OFFERED

13.13.4 KEY DEVELOPMENTS

13.13.5 SWOT ANALYSIS

13.13.6 KEY STRATEGIES

13.14 NUCHEM SCIENCES INC.

13.14.1 COMPANY OVERVIEW

13.14.2 FINANCIAL OVERVIEW

13.14.3 SERVICES OFFERED

13.14.4 KEY STRATEGIES

13.15 PARAZA PHARMA, INC.

13.15.1 COMPANY OVERVIEW

13.15.2 FINANCIAL OVERVIEW

13.15.3 SERVICES OFFERED

13.15.4 KEY DEVELOPMENTS

13.15.5 KEY STRATEGIES

14 APPENDIX

14.1 REFERENCES

14.2 RELATED REPORTS

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS

TABLE 3 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 4 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR SMALL MOLECULE DRUG, BY REGION, 2023-2030 (USD MILLION)

TABLE 5 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR BIOLOGICS DRUG, BY REGION, 2023-2030 (USD MILLION)

TABLE 6 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2023-2030 (USD MILLION)

TABLE 7 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES, BY REGION, 2023-2030 (USD MILLION)

TABLE 8 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR PHARMACEUTICAL SERVICES, BY REGION, 2023-2030 (USD MILLION)

TABLE 9 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR MEDICINAL CHEMISTRY, BY REGION, 2023-2030 (USD MILLION)

TABLE 10 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR BIOLOGICAL SERVICES, BY ERGION, 2023-2030 (USD MILLION)

TABLE 11 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR MEDICATION, BY REGION, 2023-2030 (USD MILLION)

TABLE 12 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 13 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR ONCOLOGY, BY REGION, 2023-2030 (USD MILLION)

TABLE 14 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR CARDIOVASCULAR DISEASES, BY REGION, 2023-2030 (USD MILLION)

TABLE 15 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR RESPIRATORY DISEASES, BY REGION, 2023-2030 (USD MILLION)

TABLE 16 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR DIABETES, BY REGION, 2023-2030 (USD MILLION)

TABLE 17 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR OTHERS, BY REGION, 2023-2030 (USD MILLION)

TABLE 18 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 19 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR HIGH THROUGHPUT SCREENING COMPANIES, BY REGION, 2023-2030 (USD MILLION)

TABLE 20 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR BIOCHIPS, BY REGION, 2023-2030 (USD MILLION)

TABLE 21 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR PHARMACOGENOMICS AND PHARMACOGENETICS, BY REGION, 2023-2030 (USD MILLION)

TABLE 22 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR METABOLOMICS, BY REGION, 2023-2030 (USD MILLION)

TABLE 23 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR OTHERS, BY REGION, 2023-2030 (USD MILLION)

TABLE 24 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR END USER, BY REGION, 2023-2030 (USD MILLION)

TABLE 25 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION)

TABLE 26 LOBAL DRUG DISCOVERY SERVICES MARKET, FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2023-2030 (USD MILLION)

TABLE 27 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR OTHERS, BY REGION, 2023-2030 (USD MILLION)

TABLE 28 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)

TABLE 29 NORTH AMERICA: DRUG DISCOVERY SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)

TABLE 30 NORTH AMERICA: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 31 NORTH AMERICA: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2023-2030 (USD MILLION)

TABLE 32 NORTH AMERICA: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 33 NORTH AMERICA: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 34 NORTH AMERICA: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 35 US: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 36 US: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)

TABLE 37 US: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 38 US: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 39 US: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 40 CANADA: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 41 CANADA: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)

TABLE 42 CANADA: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 43 CANADA: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 44 CANADA: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 45 EUROPE: DRUG DISCOVERY SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)

TABLE 46 EUROPE: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 47 EUROPE: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)

TABLE 48 EUROPE: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 49 EUROPE: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 50 EUROPE: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 51 GERMANY: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 52 GERMANY: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)

TABLE 53 GERMANY: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 54 GERMANY: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 55 GERMANY: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 56 FRANCE: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 57 FRANCE: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)

TABLE 58 FRANCE: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 59 FRANCE: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 60 FRANCE: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 61 UK: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 62 UK: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)

TABLE 63 UK: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 64 UK: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 65 UK: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 66 ITALY: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 67 ITALY: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)

TABLE 68 ITALY: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 69 ITALY: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 70 ITALY: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 71 SPAIN: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 72 SPAIN: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)

TABLE 73 SPAIN: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 74 SPAIN: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 75 SPAIN: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 76 REST OF EUROPE: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 77 REST OF EUROPE: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)

TABLE 78 REST OF EUROPE: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 79 REST OF EUROPE: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 80 REST OF EUROPE: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 81 ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)

TABLE 82 ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 83 ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)

TABLE 84 ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 85 ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 86 ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 87 CHINA: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 88 CHINA: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)

TABLE 89 CHINA: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 90 CHINA: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 91 CHINA: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 92 JAPAN: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 93 JAPAN: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)

TABLE 94 JAPAN: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 95 JAPAN: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 96 JAPAN: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 97 INDIA: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 98 INDIA: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)

TABLE 99 INDIA: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 100 INDIA: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 101 INDIA: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 102 AUSTRALIA: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 103 AUSTRALIA: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)

TABLE 104 AUSTRALIA: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 105 AUSTRALIA: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 106 AUSTRALIA: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 107 SOUTH KOREA: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 108 SOUTH KOREA: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)

TABLE 109 SOUTH KOREA: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 110 SOUTH KOREA: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 111 SOUTH KOREA: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 112 REST OF ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 113 REST OF ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)

TABLE 114 REST OF ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 115 REST OF ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 116 REST OF ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 117 REST OF THE WORLD: DRUG DISCOVERY SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)

TABLE 118 REST OF THE WORLD: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 119 REST OF THE WORLD: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)

TABLE 120 REST OF THE WORLD: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 121 REST OF THE WORLD: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 122 REST OF THE WORLD: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 123 MIDDLE EAST: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 124 MIDDLE EAST: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)

TABLE 125 MIDDLE EAST: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 126 MIDDLE EAST: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 127 MIDDLE EAST: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 128 AFRICA: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 129 AFRICA: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)

TABLE 130 AFRICA: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 131 AFRICA: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 132 AFRICA: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 133 LATIN AMERICA: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 134 LATIN AMERICA: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)

TABLE 135 LATIN AMERICA: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 136 LATIN AMERICA: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 137 LATIN AMERICA: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 138 MAJOR MANUFACTURERS IN DRUG DISCOVERY SERVICES MARKET

TABLE 139 MOST ACTIVE PLAYER IN DRUG DISCOVERY SERVICES MARKET

TABLE 140 SERVICE LAUNCH

TABLE 141 MERGERS & ACQUISITIONS

TABLE 142 PARTNERSHIP/COLLABORATION

TABLE 143 THERMO FISHER SCIENTIFIC INC.: SERVICES OFFERED

TABLE 144 ARAGEN LIFE SCIENCES PVT. LTD.: SERVICES OFFERED

TABLE 145 ARAGEN LIFE SCIENCES PVT.: KEY DEVELOPMENTS

TABLE 146 PIRAMAL PHARMA SOLUTIONS: SERVICES OFFERED

TABLE 147 CURIA GLOBAL, INC.: SERVICES OFFERED

TABLE 148 CURIA GLOBAL, INC.: KEY DEVELOPMENTS

TABLE 149 CHARLES RIVER LABORATORIES: SERVICES OFFERED

TABLE 150 CHARLES RIVER LABORATORIES: KEY DEVELOPMENTS

TABLE 151 EUROFINS SCIENTIFIC: SERVICES OFFERED

TABLE 152 EUROFINS SCIENTIFIC: KEY DEVELOPMENTS

TABLE 153 IQVIA: SERVICES OFFERED

TABLE 154 EVOTEC: SERVICES OFFERED

TABLE 155 EVOTEC: KEY DEVELOPMENTS

TABLE 156 WUXI APPTEC CO., LTD.: SERVICES OFFERED

TABLE 157 WUXI APPTEC CO., LTD.: KEY DEVELOPMENTS

TABLE 158 LABORATORY CORPORATION OF AMERICA HOLDINGS: SERVICES OFFERED

TABLE 159 SELVITA: SERVICES OFFERED

TABLE 160 SELVITA: KEY DEVELOPMENTS

TABLE 161 SYGNATURE DISCOVERY: SERVICES OFFERED

TABLE 162 SYGNATURE DISCOVERY: KEY DEVELOPMENTS

TABLE 163 SYMERES: SERVICES OFFERED

TABLE 164 SYMERES: KEY DEVELOPMENTS

TABLE 165 NUCHEM SCIENCES INC.: SERVICES OFFERED

TABLE 166 NUCHEM SCIENCES INC.: KEY DEVELOPMENTS

TABLE 167 PARAZA PHARMA, INC.: SERVICES OFFERED

LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS

FIGURE 2 GLOBAL DRUG DISCOVERY SERVICES MARKET

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES

FIGURE 4 MARKET DYNAMICS: GLOBAL DRUG DISCOVERY SERVICES MARKET

FIGURE 5 DRIVER IMPACT ANALYSIS

FIGURE 6 RESTRAINT IMPACT ANALYSIS

FIGURE 7 VALUE CHAIN ANALYSIS: GLOBAL DRUG DISCOVERY SERVICES MARKET

FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL DRUG DISCOVERY SERVICES MARKET

FIGURE 9 GLOBAL DRUG DISCOVERY SERVICES MARKET SHARE (%), BY DRUG TYPE, 2021

FIGURE 10 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

FIGURE 11 GLOBAL DRUG DISCOVERY SERVICES MARKET SHARE (%), BY TYPES OF SERVICES, 2021

FIGURE 12 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2023-2030 (USD MILLION)

FIGURE 13 GLOBAL DRUG DISCOVERY SERVICES MARKET SHARE (%), BY THERAPEUTIC AREA, 2021

FIGURE 14 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

FIGURE 15 GLOBAL DRUG DISCOVERY SERVICES MARKET SHARE (%), BY TECHNOLOGY, 2021

FIGURE 16 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

FIGURE 17 GLOBAL DRUG DISCOVERY SERVICES MARKET SHARE (%), BY END USER, 2021

FIGURE 18 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

FIGURE 19 GLOBAL DRUG DISCOVERY SERVICES MARKET SHARE (%), BY REGION, 2021

FIGURE 20 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)

FIGURE 21 NORTH AMERICA: DRUG DISCOVERY SERVICES MARKET SHARE (%), BY COUNTRY, 2021

FIGURE 22 EUROPE DRUG DISCOVERY SERVICES MARKET SHARE (%), BY COUNTRY, 2021

FIGURE 23 ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET SHARE (%), BY COUNTRY, 2021

FIGURE 24 REST OF THE WORLD: DRUG DISCOVERY SERVICES MARKET SHARE (%), BY REGION, 2021

FIGURE 25 BENCHMARKING OF MAJOR COMPETITORS

FIGURE 26 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN DRUG DISCOVERY SERVICES MARKET

FIGURE 27 MAJOR PLAYERS SALES & OPERATING INCOME, 2021

FIGURE 28 MAJOR PLAYERS R&D EXPENDITURE, 2021

FIGURE 29 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 30 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS

FIGURE 31 PIRAMAL PHARMA SOLUTIONS: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 32 CHARLES RIVER LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 33 CHARLES RIVER LABORATORIES: SWOT ANALYSIS

FIGURE 34 EUROFINS SCIENTIFIC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 35 EUROFINS SCIENTIFIC: SWOT ANALYSIS

FIGURE 36 IQVIA: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 37 IQVIA: SWOT ANALYSIS

FIGURE 38 EVOTEC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 39 WUXI APPTEC CO., LTD.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 40 WUXI APPTEC CO., LTD.: SWOT ANALYSIS

FIGURE 41 LABORATORY CORPORATION OF AMERICA HOLDINGS: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 42 SELVITA: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 43 SELVITA: SWOT ANALYSIS

FIGURE 44 SYGNATURE DISCOVERY: SWOT ANALYSIS

FIGURE 45 SYMERES: SWOT ANALYSIS